FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(036662848)" | Ketamine | 30 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 50 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 50 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 20 mg/2 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 20 mg/2 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 50 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ketamine Hydrochloride | 50 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Labetalol | 15 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Labetalol Hydrochloride | 20 mg/4 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Labetalol Hydrochloride | 20 mg/4 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 200 mg/10 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 100 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 100 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 100 mg/10 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 100 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 200 mg/10 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine; Epinephrine | 10 mg/3 mL; 10 ug/3 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine; Epinephrine | 5 mg/3 mL; 10 ug/3 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine; Sodium Bicarbonate | 9.1 mg/10 mL; 7.6 mg/10 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine; Sodium Bicarbonate | 9.1 mg/1 mL; 7.6 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine | 50 mg/50 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine Sulfate | 30 mg/30 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine Sulfate | 50 mg/50 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine Sulfate | 30 mg/30 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine | 5 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Oxytocin | 500000 U/500 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Phenylephrine Hydrochloride | 15 g/1500 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Rocuronium Bromide | 30 g/3 L | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Rocuronium Bromide | 30 g/3 L | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Rocuronium Bromide | 30 g/3 L | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride | 60 g/2000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride | 15 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride | 6 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride | 6 g/3 L | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride | 30 g/3 L | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride | 30 g/3 L | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride | 6 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 3750 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 3000 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 6 g/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 6 g/3 L; 6 mg/3 L | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 3750 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 6000 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 3750 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 3000 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 3000 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride | 15 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride; Fentanyl Citrate | 3000 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride; Fentanyl Citrate | 3000 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride; Fentanyl Citrate | 3000 mg/3000 mL; 6 mg/3000 mL | 2022-2 | source_no_ndc | 2026-11-10 |